Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding

[1]  S. Mann.  Calcium-channel blockers and cancer , 1996, The Lancet.

[2]  M. Rocco,et al.  Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. , 1996, JAMA.

[3]  P. Hamet,et al.  Cancer and Hypertension: An Unresolved Issue , 1996 .

[4]  M. Stampfer,et al.  Observational studies of drug safety , 1996, The Lancet.

[5]  L. Ferrucci,et al.  Calcium-channel blockade and incidence of cancer in aged populations , 1996, The Lancet.

[6]  W. Koenig,et al.  Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993. , 1996, European heart journal.

[7]  J. Slattery,et al.  Blood pressure and risk of stroke in patients with cerebrovascular disease , 1996, BMJ.

[8]  J. Guralnik,et al.  Do calcium channel blockers increase the risk of cancer? , 1996, American journal of hypertension.

[9]  U. Goldbourt,et al.  Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. , 1996, Journal of the American College of Cardiology.

[10]  M. Sevick,et al.  Antagonism to calcium antagonists , 1996, The Lancet.

[11]  J. Guralnik,et al.  Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old , 1996, The Lancet.

[12]  Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.

[13]  O. Axelson,et al.  Case-control study on colon cancer regarding previous diseases and drug intake. , 1996, International journal of oncology.

[14]  S. Yusuf,et al.  Verapamil following uncomplicated myocardial infarction: promising, but not proven. , 1996, The American journal of cardiology.

[15]  M. Pahor,et al.  A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS) , 1996, The American journal of cardiology.

[16]  G. Mancia,et al.  How safe are calcium antagonists in hypertension and coronary heart disease? , 1996, Journal of hypertension.

[17]  B. Psaty,et al.  Corrections to the nifedipine meta-analysis. , 1996, Circulation.

[18]  C. Held,et al.  Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) , 1996, European heart journal.

[19]  J. Cutler,et al.  Blood Pressure and Mortality Among Men With Prior Myocardial Infarction , 1995 .

[20]  J. Guralnik,et al.  Long‐Term Survival and Use of Antihypertensive Medications in Older Persons , 1995, Journal of the American Geriatrics Society.

[21]  J. Buring,et al.  Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. , 1995, JAMA.

[22]  T. Raghunathan,et al.  The risk of myocardial infarction associated with antihypertensive drug therapies. , 1995, JAMA.

[23]  B. Troost,et al.  Surgical bleeding: unexpected effect of a calcium antagonist , 1995, BMJ.

[24]  K. Shimamoto,et al.  Survey of current drug therapy for elderly hypertension , 1995 .

[25]  H. Matsuoka.  A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension--The GLANT Study. Study Group on Long-term Antihypertensive Therapy. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

[26]  M. Abdelnoor,et al.  Association between various drugs used for hypertension and risk of acute myocardial infarction. , 1995, Blood pressure.

[27]  S. Yusuf,et al.  Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. , 1994, Circulation.

[28]  M. Kaste,et al.  A Randomized, Double‐blind, Placebo‐Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke , 1994, Stroke.

[29]  A. Tverdal,et al.  Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study , 1994, Journal of hypertension.

[30]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[31]  M. Hennerici,et al.  Meta-Analysis of Oral Nimodipine Trials in Acute Ischemic Stroke , 1994 .

[32]  R. Collins,et al.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.

[33]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[34]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[35]  W. Hall,et al.  Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy , 1992, Annals of Internal Medicine.

[36]  C. Dollery,et al.  Medical Research Council trial of treatment of hypertension in older adults: principal results. , 1992 .

[37]  P. Tagliaferri,et al.  Verapamil upregulates sensitivity of human colon and breast cancer cells to LAK-cytotoxicity in vitro. , 1991, European journal of cancer.

[38]  C. Furberg,et al.  Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. , 1991, The American journal of cardiology.

[39]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.

[40]  S. Yusuf,et al.  Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials. , 1991, JAMA.

[41]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[42]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[43]  Robinson Mj,et al.  Calcium antagonists in the management of subarachnoid haemorrhage. , 1990 .

[44]  G. Teasdale,et al.  Calcium antagonists in the management of subarachnoid haemorrhage. , 1990, Cerebrovascular and brain metabolism reviews.

[45]  J. F. Hansen,et al.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) , 1990, The American journal of cardiology.

[46]  B. Henderson,et al.  Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.

[47]  C. Furberg,et al.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.

[48]  G. Murray,et al.  Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. , 1989, BMJ.

[49]  Eli Warnock,et al.  The effect of diltiazem on mortality and reinfarction after myocardial infarction. , 1989, The New England journal of medicine.

[50]  K. McPherson,et al.  Secondary prevention of vascular disease by prolonged antiplatelet treatment , 1988, British medical journal.

[51]  M. Benson,et al.  Calcium channel antagonists delay regression of androgen‐dependent tissues and suppress gene activity associated with cell death , 1988, The Prostate.

[52]  R Collins,et al.  Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. , 1987, Statistics in medicine.

[53]  Joy,et al.  Trial of early nifedipine in acute myocardial infarction: the Trent study. , 1986, British medical journal.

[54]  K. Bailey,et al.  Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methods. , 1986, Circulation.

[55]  A. Feinstein,et al.  Exclusion bias and the false relationship of reserpine and breast cancer. , 1985, Archives of internal medicine.

[56]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[57]  J. Fleiss,et al.  Effect of digitalis treatment on survival after acute myocardial infarction. , 1985, The American journal of cardiology.

[58]  S. Shapiro,et al.  Reserpine use in relation to breast cancer. , 1974, Lancet.

[59]  R. Doll,et al.  Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. , 1974, Lancet.

[60]  Desmond,et al.  Placebo controlled trial of felodipine in patients with mild to moderate heart failure , 2022 .